Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Dr. Prem Aggarwal

Dr Prem Aggarwal, (MD Medicine, DNB Cardiology) is a Cardiologist by profession and also the Co-founder and Chairman of Medical Dialogues. He focuses on news and perspectives about cardiology, and medicine related developments at Medical Dialogues. He can be reached out at drprem@medicaldialogues.in

Home

Dr. Prem Aggarwal

Articles By : Dr. Prem Aggarwal

Mavacamten may Improve Cardiac Biomarkers in HFpEF Patients, Early trial Results Show Promise

Dr. Prem Aggarwal8 Oct 2024 9:00 AM IST

USA: A recent study from the EMBARK-HFpEF trial has revealed promising results regarding using mavacamten, a cardiac myosin inhibitor, in patients...

Urban noise pollution may impact CV risk prediction and prognosis after heart attack: Study

Dr. Prem Aggarwal8 Oct 2024 6:45 AM IST

Research from two studies in different European cities highlights that urban noise pollution has a significant negative impact on heart health,...

ADMIRE Trial Confirms Safety and Effectiveness of Pulsed Field Ablation for Paroxysmal AF

Dr. Prem Aggarwal7 Oct 2024 9:00 AM IST

USA: The ADMIRE pivotal trial has provided significant insights into using pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation,...

Semaglutide effective as add on therapy for patients with hypertension and obesity, finds research

Dr. Prem Aggarwal7 Oct 2024 9:00 AM IST

A new study published in the European Heart Journal showed that semaglutide is a helpful additional medication for the individuals who are obese and...

Gadolinium Enhancement Improves Sudden Cardiac Death in kids with Hypertrophic Cardiomyopathy: Study

Dr. Prem Aggarwal5 Oct 2024 8:00 AM IST

Researchers have found that late gadolinium enhancement (LGE) by cardiovascular magnetic resonance imaging (CMR) is an important predictor of sudden...

Kidney dysfunction may predict sudden cardiac death in patients with heart failure: Study

Dr. Prem Aggarwal5 Oct 2024 5:00 AM IST

Patients with congestive heart failure (CHF) having a compromised blood supply, are at greater risk of sudden cardiac death (SCD). With an estimated...

Study Reveals Different CV Risks for Insomnia Medications: Z-Drugs Safe, Benzodiazepines Raise Concerns

Dr. Prem Aggarwal5 Oct 2024 1:00 AM IST

China: As insomnia continues to affect millions globally, the choice of treatment options remains crucial for patient health. Recent studies highlight...

FDA approves flurpiridaz F-18 for diagnosing coronary artery disease

Dr. Prem Aggarwal4 Oct 2024 9:15 AM IST

The U.S. Food and Drug Administration (FDA) has approved flurpiridaz F-18 (Flyrcado; GE Healthcare), a first-of-its-kind positron emission tomography...

Presence of subclinical atherosclerosis marker of mortality and its progression increases risk of death, unravels study

Dr. Prem Aggarwal4 Oct 2024 9:15 AM IST

The progression of atherosclerosis in people who have no symptoms of it is independently associated with the risk of dying from any cause, according...

HDL cholesterol levels not linked to risk of developing movement disorders, suggests research

Dr. Prem Aggarwal4 Oct 2024 6:15 AM IST

HDL cholesterol levels not linked to risk of developing movement disorders, suggests research published in the Innovations in Clinical...

Sacubitril/Valsartan Shows No Superiority Over Enalapril in Pediatric HF, Study Finds

Dr. Prem Aggarwal3 Oct 2024 9:00 AM IST

Researchers have established that sacubitril/valsartan, an angiotensin receptor-neprilysin inhibitor (ARNI), is not superior to enalapril in the...

Early Dapagliflozin Administration Cuts Heart Failure Admissions, Study Finds

Dr. Prem Aggarwal3 Oct 2024 9:00 AM IST

Japan: A recent study has shed light on the effects of early versus late administration of dapagliflozin in patients suffering from decompensated...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok